Jul 22, 2021 9:00am EDT Todos Medical Receives New FDA Certificate of Free Sale for Tollovid Daily™ Including 3CL Protease Inhibitor Claim
Jul 19, 2021 8:31am EDT Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement with Fosun Pharma
May 04, 2021 8:30am EDT Todos Medical Receives FDA Certificate of Free Sale for New 5-Day Tollovid Dosing Regimen
Apr 22, 2021 11:35am EDT Todos Medical Acquires Provista Diagnostics and Its Proprietary Videssa Breast Cancer Blood Test
Apr 19, 2021 10:30am EDT Todos Medical Launches Phase 2 Clinical Trial of Its Antiviral 3CL Protease Inhibitor NLC-V-01 (Tollovir) in Hospitalized COVID-19 Patients
Apr 08, 2021 9:27am EDT Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform
Apr 01, 2021 7:00am EDT Todos Medical Completes Automation Equipment Installation and Training for Meadowlands Diagnostics
Mar 30, 2021 9:23am EDT Todos Medical Enters Into Distribution Partnership with Osang Healthcare for the GeneFinder Plus™ COVID-19 Plus RealAMP Kit in the United States
